Invention Grant
- Patent Title: Quinazoline derivatives as TAM family kinase inhibitors
-
Application No.: US15038038Application Date: 2014-11-19
-
Publication No.: US09771333B2Publication Date: 2017-09-26
- Inventor: Zaihui Zhang
- Applicant: SIGNALCHEM LIFESCIENCES CORP.
- Applicant Address: CA Richmond, BC
- Assignee: SignalChem Lifesciences Corp.
- Current Assignee: SignalChem Lifesciences Corp.
- Current Assignee Address: CA Richmond, BC
- Agency: BioMed IP
- International Application: PCT/US2014/066467 WO 20141119
- International Announcement: WO2015/077375 WO 20150528
- Main IPC: C07D239/88
- IPC: C07D239/88 ; C07D405/12 ; C07D239/93 ; C07D417/12 ; C07D405/14 ; C07D413/14 ; C07D417/14 ; C07D413/12
Abstract:
Disclosed are compounds, compositions and methods for treating diseases, syndromes, conditions and disorders that are affected by the modulation of the activity of, e.g., the inhibition of, one or more members of the TAM family kinases.
Public/Granted literature
- US20160297775A1 QUINAZOLINE DERIVATIVES AS TAM FAMILY KINASE INHIBITORS Public/Granted day:2016-10-13
Information query
